This application is a national stage application under 35 U.S.C. §371 from PCT Application No. PCT/GB2005/001572, filed Apr. 22, 2005, which claims the priority benefit of Great Britain Application No. 0409197.1, filed Apr. 24, 2004.
This invention relates to dose counter mechanisms for medicament delivery devices, and in particular to dose counter mechanisms for use with dry powder inhalers.
Dry powder inhalers, such as the CLICKHALER® inhaler produced by Innovata Biomed in the UK and described in European Patent No. 0539469, preferably include a dose counter mechanism for providing an indication of the number of doses that have been administered to a patient and/or the number of doses that remain in the inhaler. Conventional dose counter mechanisms for use with dry powder inhalers comprise a ratchet mechanism with indicia being carried by the ratchet wheel.
Attempts to improve conventional dose counter mechanisms have been made. In particular, UK Patent Application No. 0115519.1 (Publication No. GB 2366208) describes an inhaler dose meter comprising a tape wound on a dispensing spool, the free end of the tape being fixed to a receiving spool. The receiving spool includes a number of teeth that are engaged by a pawl each time the mouthpiece cover is closed, such that the receiving spool is rotated by a predetermined degree following each closure of the mouthpiece cover. A transparent window in the inhaler housing enables a user to view indicia carried by the tape wound on the receiving spool. Each rotation of the receiving spool causes a greater length of the tape to become wound onto the spool, such that the indicia visible though the transparent window are advanced.
However, the dose counter described by GB 2366208 suffers from many disadvantages, including the dose counter having many moving parts and also the poor visibility of the indicia carried by the tape.
There has now been devised an improved dose counter mechanism which overcomes or substantially mitigates the above-mentioned and/or other disadvantages associated with the prior art.
According to a first aspect of the invention, there is provided a dose counter mechanism suitable for use with a medicament delivery device, the mechanism comprising a rollable tape provided with indicia, a tape dispenser housing, and a tape collector spool, the dispenser housing and the tape collector spool being connected by a tape display area.
The dose counter mechanism according to the invention is advantageous principally because the only necessarily moving parts of the dose counter mechanism are the tape collector spool and the rollable tape. The dose counter mechanism according to the invention is therefore simpler and less expensive to manufacture, and may be less prone to failure, than prior art mechanisms. In addition, the tape display area enables the indicia carried by the tape to be presented in a more visible manner than for prior art mechanisms.
The rollable tape may be formed of a plastics material. The indicia are preferably printed on a surface of the tape, and preferably take the form of a series of numbers that indicate either the number of doses administered or the number of doses remaining within the medicament delivery device.
The tape dispenser housing preferably comprises an enclosure within which a roll of the tape is housed, and an opening through which the tape exits the tape dispenser housing. Most preferably, the tape dispenser housing has an opening that is sufficiently large for the roll of tape to be introduced into the tape dispenser housing, but is configured so as to retain the roll of tape within the tape dispenser housing, during use. In preferred embodiments, the tape dispenser housing comprises an enclosing wall having a generally C-shaped cross-section, and end flanges that prevent any lateral movement of the roll of tape.
It is particularly preferred that the tape that is held in the tape dispenser housing is formed into a simple roll, without being wound on a bobbin or the like. This greatly simplifies the manufacturing process.
The tape display area preferably has a smooth and generally flat surface that the tape overlies in use, at least one of the indicia provided on the part of the tape overlying the tape display area preferably being visible to a user. The tape may be transparent such that the tape display area forms the visible background for the indicia. In this case, the tape display area is preferably coloured distinctly relative to the colour of the indicia.
The collector spool is preferably rotatably mounted within a collector spool housing. The dispenser housing, the collector spool housing, and the tape display area are preferably formed as a single component, preferably by injection moulding in a plastics material.
A retaining clip is preferably also provided to ensure that the tape is sufficiently taut for the indicia to be readily visible. The retaining clip may also act to ensure that the tape lies flat against the tape display area during use, and to assist in retaining the roll of tape within the tape dispenser housing.
The dose counter mechanism preferably includes an actuator that acts to rotate the collector spool appropriately during use. In particular, the actuator preferably rotates the collector spool by a pre-determined degree each time a dose of medicament is dispensed from the medicament delivery device. Most preferably, this rotation of the collector spool by a pre-determined degree each time a dose of medicament is dispensed from the medicament delivery device causes the indicia visible to the user to change, preferably to an adjacent indicia provided on the tape. The actuator is therefore preferably operably linked to the actuator of the medicament delivery device that enables or causes a dose of medicament to be dispensed. Most preferably, the actuator of the dose counter mechanism and the actuator of the medicament delivery have a common component.
Where the actuator of the medicament delivery device is displaced along a linear path and then returned to its inoperative position each time a dose of medicament is dispensed, the actuator of the dose counter mechanism is also preferably displaced along a linear path and then returned to its inoperative position each time a dose of medicament is dispensed. The actuator of the dose counter mechanism is therefore preferably adapted to rotate the collector spool by a pre-determined degree on being displaced along a linear path and then returned to its inoperative position.
In presently preferred embodiments, the collector spool comprises an end plate having a plurality of projections that are engageable by the actuator, during use, to cause rotation of the collector spool. Preferably, the projections are spaced equiangularly about a peripheral part of the end plate.
The actuator preferably comprises first and second actuator arms, the first actuator arm engaging the collector spool when the actuator is displaced from its inoperative position, and the second actuator arm engaging the collector spool on the return stroke of the actuator to its inoperative position. Most preferably, the first actuator arm is engaged with a projection when the actuator is in its inoperative position, or the first actuator arm engages a projection immediately upon displacement of the actuator from its inoperative position, which then causes the first actuator arm to exert a force on the projection with which it is engaged so as to rotate the collector spool. The second actuator arm engages a projection on the return stroke of the actuator. The first and second actuator arms thus engage projections on opposite sides of the axis of rotation of the collector spool. In this way, the collector spool is rotated by the movement of the actuator.
According to a further aspect of the invention, there is provided a medicament delivery device comprising a dose counter mechanism as described above.
The medicament delivery device is preferably an inhaler, and more preferably a dry powder inhaler, such as the CLICKHALER® inhaler produced by Innovata Biomed in the UK and described in European Patent No. 0539469 or the combination therapy dry powder inhaler described in the published International patent application WO 01/39823. By a dry powder inhaler is meant an inhaler of the type in which a unit dose of medicament powder, either packaged as such or metered from a bulk reservoir of medicament, is presented to an airway and is then entrained in an airflow passing through the airway. The airflow is most commonly generated by the patient's act of inhalation.
According to a more specific aspect of the invention, there is thus provided an inhaler comprising a dose counter mechanism as described above.
A variety of medicaments may be administered by using the inhaler of the invention. Such medicaments are generally suitable for the treatment of asthma, COPD and respiratory infections. Such medicaments include, but are not limited to β2-agonists, eg fenoterol, formoterol, pirbuterol, reproterol, rimiterol, salbutamol, salmeterol and terbutaline; non-selective beta-stimulants such as isoprenaline; xanthine bronchodilators, eg theophylline, aminophylline and choline theophyllinate; anticholinergics, eg ipratropium bromide, oxitropium and tiotropium; mast cell stabilisers, eg sodium cromoglycate and ketotifen; bronchial anti-inflammatory agents, eg nedocromil sodium; and steroids, eg beclomethasone, fluticasone, budesonide, flunisolide, triamcinolone, mometasone and ciclesonide; and/or salts or derivatives thereof.
Specific combinations of medicaments which may be mentioned include combinations of steroids and β2-agonists. Examples of such combinations are beclomethasone dipropionate and formoterol; beclomethasone dipropionate and salmeterol; fluticasone and formoterol; fluticasone and salmeterol; budesonide and formoterol; budesonide and salmeterol; flunisolide and formoterol; flunisolide and salmeterol; ciclesonide and salmeterol; ciclesonide and formoterol; mometasone and salmeterol; and mometasone and formoterol.
Further medicaments which may be mentioned include systemically active materials, such as proteinaceous compounds and/or macromolecules, for example hormones and mediators, such as insulin, human growth hormone, leuprolide and alpha interferon, growth factors, anticoagulants, immunomodulators, cytokines and nucleic acids.
The invention will now be described in greater detail, by way of illustration only, with reference to the accompanying drawings, in which
A dose counter mechanism according to the invention is shown in the Figures. The dose counter mechanism is intended for use with a dry powder inhaler (not shown in the Figures), for example the CLICKHALER® inhaler produced by Innovata Biomed in the UK and described in European Patent No 0539469B. Another example of a dry powder inhaler in which the dose counter mechanism may be incorporated is that described in European Patent No 1233805B. Such an inhaler is used for the delivery of two different medicaments.
The dose counter mechanism comprises a tape housing 10, a tape 20, a retaining clip 30, a collector spool 40, and an actuator 50.
The tape housing 10 is injection moulded in plastics material as a single component, and is shown in
The rear wall 13 is orientated substantially along the longitudinal axis of the tape housing 10, and is situated slightly below and rearward (as viewed in
A tape display plate 15 extends from a lower part of the dispenser housing 14 to the collector spool housing 16 at the lower end of the tape housing 10 (as viewed in
The collector spool housing 16 is cylindrical in form with one end extending from the side wall 11 of the tape housing 10, and the other end being open. A slot 17 is provided in the wall of the collector spool housing 16 through which the tape 20 enters before being wound on the collector spool 40 (part of which is shown in
The tape 20 is shown in
The retaining clip 30 is formed from a resilient metal, such as mild steel, and has the form shown in
The collector spool 40 comprises an end plate 42 that is in abutment with the open end of the collector spool housing 16, and a cylindrical shaft (not visible in
The end plate 42 has the form of a circular disc, with three pegs 44 provided on the outwardly-facing surface of the end plate 42. The three pegs 44 are spaced equiangularly about a peripheral part of the outwardly-facing surface of the end plate 42, and each peg 44 comprises a cylindrical neck and an enlarged head.
In a fully charged dry powder inhaler, the dose counter mechanism is assembled such that the majority of the tape 20 is held in the dispenser housing 14 in the form of a roll 24. As described above, the tape 20 extends along the front surface of the tape display plate 15, and the end of the tape 20 is fixed to the collector spool 40. In this configuration, the printed number 22 that indicates the number of doses contained within the fully charged dry powder inhaler is located over a viewing part of the tape display plate 15. The dry powder inhaler has a transparent window that overlies the viewing part of the tape display plate 15, such that this printed number 22 is visible.
From this fully charged configuration, the user depresses and then releases the actuator 50 of the dry powder inhaler to dispense a dose of medicament. The actuator 50 is spring-loaded within the dry powder inhaler so that it returns to its inoperative configuration once released by the user.
Each depression and release of the actuator 50 causes the collector spool 40 to be rotated through 120°, thereby causing a pre-determined length of the tape 20 to be wound onto the collector spool 40. This, in turn, causes the tape 20 to be advanced along the tape display plate 15, such that the next printed number 22 in the series is located over a viewing part of the tape display plate 15 and hence visible through the transparent window of the dry powder inhaler.
This action is achieved using an actuator 50 having the form shown in
The actuator 50 also has a portion that engages the end plate 42 of the collector spool 40 so as to effect rotation of the collector spool 40 on depression and release of the actuator button, as discussed above. This portion comprises downwardly-extending first and second actuator arms 54,56, each with an arcuate engagement member 55,57 at its lower end for engaging a peg 44 of the end plate 42. In particular, the engagement member 55 of the first actuator arm 54 is adapted to engage the upper surface of a peg 44, pushing that peg 44 downwards, and the engagement member 57 of the second actuator arm 56 is hooked, so as to engage the lower surface of a peg 44.
The first and second actuator arms 54,56 are shown in
Depression of the actuator button, and hence downward displacement of the actuator 50, causes the engagement member 55 of the first actuator arm 54 to engage the upper surface of the peg 44 with which it is in contact, and urge that peg 44 downwards. This causes the endplate 42, and hence the collector spool 40, to rotate in a clockwise direction. The engagement member 57 of the second actuator arm 56 will be displaced downwardly by this action, rotating the end plate 42 through 120° from the configuration shown in
Release of the actuator button, and hence upward displacement of the actuator 50, will cause the engagement member of the second actuator arm 56 to return to its rest position, at which it engages a peg 44 from below, thereby holding the endplate 42, and hence the collector spool 40, in the position to which it has been rotated. The arrangement is then once again as shown in
The remaining parts of the actuator 50 are specific to the dry powder inhaler with which the dose counter mechanism is used, but the actuator 50 will include means for enabling a dose of medicament to be dispensed on depression of the actuator 50.
As described above, each depression and release of the actuator button will cause a dose of medicament to be dispensed, and the collector spool 40 to rotate 120° so that the next number 22 in the series of numbers printed on the tape 20 is visible to the user.
Number | Date | Country | Kind |
---|---|---|---|
0409197.1 | Apr 2004 | GB | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/GB2005/001572 | 4/22/2005 | WO | 00 | 10/19/2006 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2005/102430 | 11/3/2005 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1858735 | Goodsell | May 1932 | A |
2587215 | Priestly | Feb 1952 | A |
3008609 | Sessions | Nov 1961 | A |
3439823 | Morane | Apr 1969 | A |
3798054 | Kawata et al. | Mar 1974 | A |
3854626 | Krechmar | Dec 1974 | A |
3874381 | Baum | Apr 1975 | A |
3876269 | Fisher et al. | Apr 1975 | A |
4047635 | Bennett, Jr. | Sep 1977 | A |
4114615 | Wetterlin | Sep 1978 | A |
4174034 | Hoo | Nov 1979 | A |
4200099 | Guenzel et al. | Apr 1980 | A |
4274403 | Struve | Jun 1981 | A |
4524769 | Wetterlin | Jun 1985 | A |
4534343 | Nowacki et al. | Aug 1985 | A |
4570630 | Elliott et al. | Feb 1986 | A |
4604847 | Moulding, Jr. et al. | Aug 1986 | A |
4624442 | Duffy et al. | Nov 1986 | A |
4627432 | Newell et al. | Dec 1986 | A |
4635829 | Brittingham, Jr. | Jan 1987 | A |
4668218 | Virtanen | May 1987 | A |
4811731 | Newell et al. | Mar 1989 | A |
4860740 | Kirk et al. | Aug 1989 | A |
4882210 | Romberg et al. | Nov 1989 | A |
4895719 | Radhakrishnan et al. | Jan 1990 | A |
4907583 | Wetterlin et al. | Mar 1990 | A |
4934358 | Nilsson et al. | Jun 1990 | A |
4950365 | Evans | Aug 1990 | A |
5002048 | Makiej, Jr. | Mar 1991 | A |
5007419 | Weinstein et al. | Apr 1991 | A |
5042472 | Bunin | Aug 1991 | A |
5053237 | Hendricks et al. | Oct 1991 | A |
5064083 | Alexander et al. | Nov 1991 | A |
5067491 | Taylor, II et al. | Nov 1991 | A |
5113855 | Newhouse | May 1992 | A |
5152422 | Springer | Oct 1992 | A |
5154326 | Chang et al. | Oct 1992 | A |
5161524 | Evans | Nov 1992 | A |
5169029 | Behar et al. | Dec 1992 | A |
5187512 | Kirkendall | Feb 1993 | A |
5192528 | Radhakrishnan et al. | Mar 1993 | A |
5207217 | Cocozza et al. | May 1993 | A |
5208226 | Palmer | May 1993 | A |
5253782 | Gates et al. | Oct 1993 | A |
5263475 | Altermatt et al. | Nov 1993 | A |
5295479 | Lankinen | Mar 1994 | A |
5301666 | Lerk et al. | Apr 1994 | A |
5347999 | Poss et al. | Sep 1994 | A |
5351683 | Chiesi et al. | Oct 1994 | A |
5394868 | Ambrosio et al. | Mar 1995 | A |
5409132 | Kooijmans et al. | Apr 1995 | A |
5411175 | Armstrong et al. | May 1995 | A |
5415162 | Casper et al. | May 1995 | A |
5435301 | Herold et al. | Jul 1995 | A |
5437267 | Weinstein et al. | Aug 1995 | A |
5437270 | Braithwaite | Aug 1995 | A |
5447151 | Bruna et al. | Sep 1995 | A |
5450160 | Tianello et al. | Sep 1995 | A |
5458135 | Patton et al. | Oct 1995 | A |
5485939 | Tucker | Jan 1996 | A |
5503144 | Bacon | Apr 1996 | A |
5520166 | Ritson et al. | May 1996 | A |
5524613 | Haber et al. | Jun 1996 | A |
5551597 | Lambelet, Jr. et al. | Sep 1996 | A |
5562231 | Lambelet, Jr. et al. | Oct 1996 | A |
5562918 | Stimpson | Oct 1996 | A |
5575280 | Gupte et al. | Nov 1996 | A |
5617845 | Poss et al. | Apr 1997 | A |
5622166 | Eisele et al. | Apr 1997 | A |
5653227 | Barnes et al. | Aug 1997 | A |
5657748 | Braithwaite | Aug 1997 | A |
5657794 | Briner et al. | Aug 1997 | A |
5664557 | Makiej, Jr. | Sep 1997 | A |
5664697 | Lambelet, Jr. et al. | Sep 1997 | A |
5676130 | Gupte et al. | Oct 1997 | A |
5678538 | Drought | Oct 1997 | A |
D389570 | Savolainen | Jan 1998 | S |
5740792 | Ashley et al. | Apr 1998 | A |
5740794 | Smith et al. | Apr 1998 | A |
5775536 | Lambelet, Jr. et al. | Jul 1998 | A |
5778873 | Braithwaite | Jul 1998 | A |
5785049 | Smith et al. | Jul 1998 | A |
5799821 | Lambelet, Jr. et al. | Sep 1998 | A |
5857457 | Hyppölä | Jan 1999 | A |
5875776 | Vaghefi | Mar 1999 | A |
5881719 | Gottenauer et al. | Mar 1999 | A |
5896855 | Hobbs et al. | Apr 1999 | A |
5904139 | Hauser | May 1999 | A |
5921237 | Eisele et al. | Jul 1999 | A |
5924417 | Braithwaite | Jul 1999 | A |
5941241 | Weinstein et al. | Aug 1999 | A |
5944660 | Kimball et al. | Aug 1999 | A |
5955439 | Green | Sep 1999 | A |
5981549 | Viner | Nov 1999 | A |
5996577 | Ohki et al. | Dec 1999 | A |
6006747 | Eisele et al. | Dec 1999 | A |
6035463 | Pawelzik et al. | Mar 2000 | A |
6065471 | Schaeffer et al. | May 2000 | A |
6065472 | Anderson et al. | May 2000 | A |
6076521 | Lindahl et al. | Jun 2000 | A |
6089227 | Nilsson | Jul 2000 | A |
6116238 | Jackson et al. | Sep 2000 | A |
6116239 | Volgyesi | Sep 2000 | A |
6119688 | Whaley et al. | Sep 2000 | A |
6125844 | Samiotes | Oct 2000 | A |
6138668 | Patton et al. | Oct 2000 | A |
6158675 | Ogi | Dec 2000 | A |
6196218 | Voges | Mar 2001 | B1 |
6220243 | Schaeffer et al. | Apr 2001 | B1 |
6234167 | Cox et al. | May 2001 | B1 |
6240918 | Ambrosio et al. | Jun 2001 | B1 |
6254854 | Edwards et al. | Jul 2001 | B1 |
6273085 | Eisele et al. | Aug 2001 | B1 |
6321747 | Dmitrovic et al. | Nov 2001 | B1 |
6324428 | Weinberg et al. | Nov 2001 | B1 |
6325241 | Garde et al. | Dec 2001 | B1 |
6328034 | Eisele et al. | Dec 2001 | B1 |
6347629 | Braithwaite | Feb 2002 | B1 |
6418926 | Chawla | Jul 2002 | B1 |
6435372 | Blacker et al. | Aug 2002 | B1 |
6443146 | Voges | Sep 2002 | B1 |
6446627 | Bowman et al. | Sep 2002 | B1 |
6484718 | Schaeffer et al. | Nov 2002 | B1 |
6523536 | Fugelsang et al. | Feb 2003 | B2 |
6543443 | Klimowicz et al. | Apr 2003 | B1 |
6553987 | Davies | Apr 2003 | B1 |
6557550 | Clarke | May 2003 | B1 |
6557552 | Cox et al. | May 2003 | B1 |
6601729 | Papp | Aug 2003 | B1 |
6616914 | Ward et al. | Sep 2003 | B2 |
6675839 | Braithwaite | Jan 2004 | B1 |
6698425 | Widerström | Mar 2004 | B1 |
6810873 | Haikarainen et al. | Nov 2004 | B1 |
6810874 | Koskela et al. | Nov 2004 | B1 |
6845772 | Braithwaite et al. | Jan 2005 | B2 |
6926003 | Seppälä | Aug 2005 | B2 |
20020066451 | Davies et al. | Jun 2002 | A1 |
20020078949 | O'Leary | Jun 2002 | A1 |
20030075172 | Johnson et al. | Apr 2003 | A1 |
20030116157 | Braithwaite et al. | Jun 2003 | A1 |
20030136406 | Seppala | Jul 2003 | A1 |
20040011357 | Braithwaite | Jan 2004 | A1 |
20040094152 | Harvey et al. | May 2004 | A1 |
20040101482 | Sanders | May 2004 | A1 |
20040236282 | Braithwaite | Nov 2004 | A1 |
20040251318 | Braithwaite | Dec 2004 | A1 |
20050121023 | Braithwaite | Jun 2005 | A1 |
Number | Date | Country |
---|---|---|
14 98 398 | Jan 1969 | DE |
0 045 522 | Feb 1982 | EP |
0 079 478 | May 1983 | EP |
0 166 294 | Oct 1989 | EP |
0 372 777 | Jun 1990 | EP |
0 424 790 | May 1991 | EP |
0 448 204 | Sep 1991 | EP |
0 469 814 | Feb 1992 | EP |
0 514 085 | Nov 1992 | EP |
0 520 440 | Dec 1992 | EP |
0 539 469 BI | May 1993 | EP |
0 573 128 | Dec 1993 | EP |
0 626 689 | Nov 1994 | EP |
0 659 432 | Jun 1995 | EP |
1 062 962 | Dec 2000 | EP |
1 106 196 | Jun 2001 | EP |
1 208 863 | May 2002 | EP |
1616592 | Jan 2006 | EP |
1196146 | Sep 2006 | EP |
3908 | Jan 1911 | GB |
1 242 211 | Aug 1971 | GB |
1 573 551 | Aug 1980 | GB |
2 041 763 | Sep 1980 | GB |
2 165 159 | Apr 1986 | GB |
2 178 965 | Feb 1987 | GB |
2 235 753 | Mar 1991 | GB |
2 248 400 | Apr 1992 | GB |
2 366 208 | Mar 2002 | GB |
2366208 | Mar 2002 | GB |
WO 9007351 | Jul 1990 | WO |
WO 9104011 | Apr 1991 | WO |
WO 9111173 | Aug 1991 | WO |
WO 9114422 | Oct 1991 | WO |
WO 9200771 | Jan 1992 | WO |
WO 9203175 | Mar 1992 | WO |
WO 9204928 | Apr 1992 | WO |
WO 9209322 | Jun 1992 | WO |
WO 9218188 | Oct 1992 | WO |
WO 9300951 | Jan 1993 | WO |
WO 9316748 | Sep 1993 | WO |
WO 9500128 | Jan 1995 | WO |
WO 9515777 | Jun 1995 | WO |
9517917 | Jul 1995 | WO |
9602231 | Feb 1996 | WO |
9608284 | Mar 1996 | WO |
WO 9700399 | Jan 1997 | WO |
9720589 | Jun 1997 | WO |
9740819 | Nov 1997 | WO |
WO 9826828 | Jun 1998 | WO |
9828033 | Jul 1998 | WO |
9831352 | Jul 1998 | WO |
WO 9830262 | Jul 1998 | WO |
WO 9831352 | Jul 1998 | WO |
WO 9912597 | Mar 1999 | WO |
WO 9913930 | Mar 1999 | WO |
WO 9926676 | Jun 1999 | WO |
WO 0012163 | Mar 2000 | WO |
WO 0064519 | Nov 2000 | WO |
WO 0117595 | Mar 2001 | WO |
0128887 | Apr 2001 | WO |
WO 0139823 | Jun 2001 | WO |
WO 0151030 | Jul 2001 | WO |
WO 0160341 | Aug 2001 | WO |
0187391 | Nov 2001 | WO |
WO 0187378 | Nov 2001 | WO |
0197889 | Dec 2001 | WO |
0200280 | Jan 2002 | WO |
0200281 | Jan 2002 | WO |
WO 02056948 | Jul 2002 | WO |
2004017914 | Mar 2004 | WO |
2004017918 | Mar 2004 | WO |
2004017942 | Mar 2004 | WO |
2004026380 | Apr 2004 | WO |
WO 2004091705 | Oct 2004 | WO |
2005060535 | Jul 2005 | WO |
2006008027 | Jan 2006 | WO |
Entry |
---|
Gerrity, T.R., “Pathophysiological and Disease Constraints on Aerosol Delivery,” Chapter 1, Respiratory Drug Delivery I, ed. Byron, P.R., CRC Press, pp. 1-38 (1990). |
Notice of Reasons for Rejection, Japan Patent Application No. 2007-508980 (Jun. 14, 2010). |
Number | Date | Country | |
---|---|---|---|
20070241025 A1 | Oct 2007 | US |